Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled sedation in the critically ill patient
2024-518521-14-00Phase 4Authorised
- Sponsor
- Hospital Universitario La Paz
- Start
- Mar 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in None comparing Inhaled isoflurane (Sedaconda) sedation with Intravenous propofol (Propofol Fresenius) sedation (2 arms). Primary endpoint: Mean number of days free of mechanical ventilation at day 28 from randomization. Planned start Mar 2025; status: authorised.
02
Drugs
isofluranepropofol
Beyond the preview
Go deeper on 2024-518521-14-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518521-14-00.